Anzeige
Meldung des Tages: Revolutionäre Entwicklung im Megatrend – Der KI-Durchbruch für Pflege und Sicherheit!
Werbung
Attraktive Knock-Outs auf Medtronic plc
Typ Hebel Bid / Ask WKN
Call
4,0 2,14 € / 2,15 €
SN1TX7
Typ Hebel Bid / Ask WKN
Put
5,1 1,69 € / 1,70 €
SD53WC
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Medtronic plc

Medtronic Aktie News

Aktie
WKN:  A14M2J ISIN:  IE00BTN1Y115 US-Symbol:  MDT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Irland
87,00 €
-1,50 €
-1,69%
17:32:32 Uhr
Depot/Watchlist
Marktkapitalisierung *
104,95 Mrd. €
Streubesitz
11,23%
KGV
23,41
Dividende
2,83 $
Dividendenrendite
3,47%
neu: Nachhaltigkeits-Score
40 %
Index-Zuordnung
S&P 500
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,25: VH3R5H
Werbung

Medtronic News

03.02.26 - PR Newswire
Medtronic advances its innovation strategy with intent to acquire CathWorks
Medtronic advances its innovation strategy with intent to acquire CathWorks PR Newswire
02.02.26 - PR Newswire
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
Medtronic Diabetes expands access to full-​stack insulin delivery solutions with Medicare access and new FDA clearances PR Newswire
23.01.26 - PR Newswire
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation PR Newswire
12.01.26 - PR Newswire
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott PR Newswire
07.01.26 - PR Newswire
Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
Study showed MiniMed™ 780G system achieved ADA-​recommended time-​in-range goals even on days users forgot to bolus PR Newswire
05.01.26 - PR Newswire
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire
19.12.25 - PR Newswire
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed PR Newswire
12.12.25 - PR Newswire
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs PR Newswire
04.12.25 - PR Newswire
Medtronic announces cash dividend for third quarter of fiscal year 2026
Medtronic announces cash dividend for third quarter of fiscal year 2026 PR Newswire
03.12.25 - PR Newswire
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Medtronic announces FDA clearance of Hugo™ robotic-​assisted surgery system for urologic surgical procedures PR Newswire
02.12.25 - PR Newswire
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott PR Newswire
18.11.25 - PR Newswire
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum PR Newswire
18.11.25 - wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Heute im Fokus: Bertelsmann, Medtronic, Biontech, Rheinmetall & Imperial Brands
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
05.11.25 - PR Newswire
Medtronic to announce financial results for its second quarter of fiscal year 2026
Medtronic to announce financial results for its second quarter of fiscal year 2026 PR Newswire
28.10.25 - PR Newswire
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system PR Newswire
26.10.25 - PR Newswire
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Three-​year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-​based blood pressure reductions PR Newswire
09.10.25 - PR Newswire
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions PR Newswire
08.10.25 - PR Newswire
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-​assisted surgery system for gynecological procedures PR Newswire
29.09.25 - PR Newswire
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes PR Newswire
19.09.25 - PR Newswire
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence PR Newswire

Newssuche

Videos

newspaper
03.02.26
2026 02 03 17 34 Trendjumper Einführung
Zunächst inormieren wir unsere Stammkunden bezüglich des bevorstehenden Seminars und bieten für ... Mehr »